hospital

The surgical facilities at the Vall d’Hebron Hospital in Barcelona were created in the 50’s. Now, half of a century later, the hospital has launched a new surgical ward for highly complex surgery. It has 10,000 square metres and 19 operating theatres with cutting-edge technology. The coordinator of surgical activity, Joan Anton Huete, said that the new block will admit “a larger number of patients” and, therefore, waiting lists will be reduced. The Hospital expects to conduct more and better operations, because the surgery will be less aggressive, a fact that can make the postoperative care easier and shorten the hospitalisation period. The new surgical block has represented an investment of €37 million.

The first bone marrow transplant in Spain was performed in Barcelona, by doctors from Sant Pau Hospital. It was on the 22^nd of May 1976 and the patient was a 13-year-old girl who suffered from acute leukaemia. Since then, 2,939 operations of this type have been carried out in Catalonia. Director of the Haematology Service at Sant Pau, Jordi Sierra, stated that 500 bone marrow transplants take place in Catalonia each year and that Sant Pau alone performed 130 operations of this kind in 2015, 23 of them on children. Bone marrow transplant survival rate varies from 70% in a young patient who is in an early stage of the disease and receives a donation from a relative, to 30% in the case of a patient over 60 years old and in an advanced stage who has a transplant from an unrelated donor, explained Sierra. However, thanks to new therapies, transplants might not be necessary for cancerous diseases in the future.

A number of different associations met this Wednesday with current Catalan President, Artur Mas, and current Catalan Minister for Social Affairs, Neus Munté, to coordinate on the hosting of refugees. "Catalonia is ready" stated Munté, although she admitted that the Spanish Government haven't told them yet "the number of refugees nor the approximate date of their arrival". In any case, the Catalan institutions and collaborative organisations will be able to host initially between 2,000 and 5,000 people. "These people are living a daily 'Paris'" stated Munté, referring to the refugees escaping military conflicts. She also emphasised that the terrorist attacks in Paris "haven't changed" the government plans in terms of hosting refugees "on the contrary, they have made us more aware of how important it is to work together". 

Researchers at the Hospital Germans Trias in Badalona (Greater Barcelona) have taken an important step toward creating a vaccine for Type 1 diabetes, which currently has no cure. The discovery, published in the scientific journal 'Plos One', consists of the preparation of nanoparticles in the laboratory that, once introduced into the body, slow down the destruction of beta cells (whose primary function is to store and release insulin). With Type 1 diabetes, the body’s immune system attacks these insulin-producing cells located in the pancreas and destroys them. Currently, to combat the disease, patients must take insulin injections. In recent years, Catalonia has become a global hub for biomedical investigation, developing cutting-edge research initiatives and participating in leading international projects. With just 0.1% of the world’s population, Catalonia accounts for nearly 1% of global scientific production and attracts 2.2% of European competitive funds and 3.5% of European Research Council (ERC) grants.

A new computational method allows the detection, within just a few hours, of the genetic alterations responsible for the formation and progression of cancer tumours. This new method manages to accurately identify almost all types of genetic changes of cancer cells in a simple, quick and precise way. It is also able to identify large-scale chromosome rearrangements, which had been difficult to be detect until this breakthrough. The new method, called SMUFIN, has been developed by the Barcelona Supercomputing Centre and the ICREA (Catalan Institution of Research and Advanced Studies), in collaboration with research groups from Barcelona, Oviedo and Heidelberg. This progress has been published by the prestigious journal 'Nature Biotechnology' and represents a significant step forward towards the personalised treatment of cancer and other illnesses.

On Tuesday evening the Barcelona-born opera tenor, Josep Carreras received the Golden Medal of the Catalan Parliament for his outstanding and internationally-recognised professional career, but also for his efforts leading a foundation that fights Leukaemia. In his acceptance speech, Carreras defended Catalonia's right to self-determination and the independence vote scheduled for the 9^th of November. Carreras, who became a true world star in the 1990s with the Three Tenors, praised the idiom "live and let live", meaning that the Spanish authorities should authorise the self-determination vote. He asked the Catalan MPs "to do whatever is necessary to ensure that the others live and let us live". His words were particularly relevant as they were said at such an important event and two days ahead of the massive pro-independence demonstration, which will take place in Barcelona on Catalonia's National Day (the 11^th of September).

During the first half of the year, the revenues of the Catalan multinational pharmaceutical company Grifols rose by 16.7% to €1.61 bilion, 75% of which came from the Bioscience division and 18% from Diagnostic. Compared to the first quarter, the proportion of total sales generated by each of the group’s divisions remains unchanged after the acquisition of Novartis' diagnostic business. The world´s third-largest blood-derivate product maker, Grifols obtained a net profit of €224.8 million, 23% more compared with the same period last year, as reported by the company to the Spanish Stock Exchange Authority (CNMV). These positive figures were achieved due to the maintenance of financial costs, made possible by improved financial conditions, despite having increased debt in absolute terms.

On Wednesday the World Health Organisation (WHO) appointed Barcelona-based researcher Pedro Alonso as the new Director of its Global Malaria Program. Alonso is a key figure in the global fight against malaria and has lead research into a vaccine to combat the life-threatening illness. He has been involved with WHO since 2011, when the organisation appointed him as the Chair of the GTS Steering Committee on the Global Technical Strategy on Malaria. Alonso is currently the Director of the Barcelona Institute for International Health Research. He is also the Head of the Department of International Health and Tropical Medicine at Barcelona's Hospital Clínic and a lecturer at Barcelona University. The physician is due to start his new position in October and is expected to give his formal recommendation on the strategy against malaria in the first quarter of 2015.

Catalonia has established a reputation as a global centre of scientific excellence, pioneering research and innovative ideas. This corner of Europe, with just 0.1% of the world’s population, accounts for nearly 1% of global scientific production. The Catalan Research system, formed of 12 internationally esteemed universities, over 60 research centres, 15 world class hospitals, and almost 9,000 innovative companies, attests to the Catalonia's ambitions in science. This territory is also a magnet of international funding: with 1.5% of Europe’s population, it receives 2.2% of European competitive funds and 3.5% of European Research Council (ERC) grants. There can be no doubt that Catalonia is now a benchmark in Southern Europe, producing frontier research and punching considerably above its weight in terms of scientific contribution.  It is attracting worldwide talent and projects, and many consider it to be fast becoming the Palo Alto of biomedical research.

A team of surgeons at the Sant Joan de Déu Hospital in the Catalan capital successfully removed a tumour from a five year old child by first preparing and practicing the “highly complex” procedure on a 3D printed tumour. The child had neuroblastoma, a difficult cancer to extirpate because of the surrounding blood vessels and arteries. In such cases, testing the procedure in advance "is key" because it allows surgeons to study the most effective way of extracting the tumour without damaging other tissues, and to test the method before surgery. This has been possible thanks to the use of a 3D replica of the tumour.

A total of 23,825 patients have to wait longer than the maximum 6-month-period to undergo one of the 14 surgeries with a guaranteed waiting time, according to the Catalan Minister of Health, Boi Ruiz. In 2013, a total of 151,009 patients underwent one of these surgeries, 3,834 more than the previous year, which represents a 2.6% increase. The number of patients who still require one of these 14 procedures in December 2013 has increased by 6% and 4,261 people, reaching 75,075 with an average waiting time of 5.78 months. On the other hand, the waiting lists for all surgeries, including the 14 specific procedures, have fallen by about 7,000 people in 2013 compared to 2012.

Barcelona’s Hospital Clínic has installed the ‘Micra’ 24mm pacemaker - equivalent to the size of a one euro coin -  in 4 patients as part of a clinical trial involving 10 medical centres and 60 patients troughout the world. This innovative wireless system is minimally invasive since it does not require any surgical procedure but is implanted in the heart through the femoral vein using a catheter. Such a procedure can be performed within 30 minutes and also reduces the patients’ risks of future infections. According to the Medical Director of the Hospital, Josep Brugada, if the clinical study is successful, it will involve a “paradigm shift”. Experts estimate it could reach hospitals within the next two or three years.

The premises of Barcelona’s Hospital de la Santa Creu i Sant Pau, the largest Art-Nouveau structure in Europe, were unveiled on Monday by the President of the Catalan Government, Artur Mas, the Vice President of the European Commission, Viviane Reding, the Spanish Minister of Public Works, Ana Pastor, and the Mayor of Barcelona, ??Xavier Trias. The Hospital was designed by Architect Lluis Domenech i Montaner over a century ago and it was divided in a set of pavilions located in a park. It has treated its very last patient in June 2009, before moving to new facilities. After 5 years of renovation works, the compound has become a centre devoted to research and innovation, now hosting renowned international institutions. The building is also looking to become a major tourist attraction, with 120,000 visitors expected each year. All the politicians present at the unveiling stressed that the rehabilitation was the result of a close collaboration between governments and institutions.

Researchers from Barcelona’s Centre for Regenerative Medicine (CMRB), the Catalan capital’s Hospital Clínic and the Salk Institute of California have successfully created three-dimensional renal structures which are virtually indistinguishable from embryonic kidneys. They have started creating kidney cells from human stem cells, and ultimately proven that these newly created cells could aggregate in vitro to form a “micro-kidney”. The team led by Juan Carlos Izpisúa, from the CMRB, said that this scientific breakthrough would facilitate the study of kidney diseases and enable scientists to work on new treatments. He added that this achievement was a great step towards developing therapies based on the use of stem cells.

Researchers of Barcelona-based Vall d’Hebron Hospital and Research Institute discovered some of the main causes of the Idiopathic Pulmonary Fibrosis, which were unknown before today. Vall d’Hebron’s study showed that a continuous exposure to feather pillows and duvets was one of the main causes of this illness as it favours the scarring of lung tissue. This disease provokes a progressive decline of lung function and leads to asphyxia because of the deterioration of the organ’s tissue. The study has been able to trace the diseases’ causes in half of the studied cases. Besides feather pillows and duvets, the persistent exposure to fungus and close contact with birds can also trigger the illness. The Catalan research allows for a new approach to the illness’ prevention and its diagnosis in the early stages. It also represents a completely new approach to this pathology in terms of treatment.